Yn dangos 61 i 75 o 436 canlyniadau
HCPC joins health and care regulators to publish 2024 whistleblowing report
The HCPC, in collaboration with eight other professional health and care regulators, has published the latest Whistleblowing disclosures report for 2024.
HCPC response to DHSC healthcare regulation consultation
As we move forward with the wider programme of regulatory reform, we welcome this consultation to consider how the powers to introduce and remove professions from regulation might be used in the future.
August bank holiday 2024 service availability
The HCPC offices will be closed on Monday 26 August for the summer bank holiday weekend
Winners of the HCPC student competition 2024 announced
Find out who won the HCPC student competition 2024, which asked students to design a learning session about social media.
August bank holiday 2023 service availability
The HCPC offices will be closed on Monday 28 August for the summer bank holiday weekend
Key findings from the Year in Registration Survey 2024
Key findings from our year in registration survey, which aims to gather insight about how students’ education and training prepares them for practice.
We have revised our standards for prescribing
The Health and Care Professions Council has recently revised our standards for prescribing, following a public consultation. The revised standards took effect on 1 September 2019.
Call-out for working group members following consultation closure
The HCPC consultation on the Standards of conduct, performance and ethics, and accompanying guidance on social media closed on 16 June 2023.
Who to contact at the HCPC?
We have listed each department and what queries they can help with.
Now open: HCPC student competition 2024! #HCPCstudentcomp
For the third year running, the HCPC has opened its student competition.
Launch of consultation for the standards of conduct, performance and ethics
Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.
HCPC statement on guidance on health and character and suicidal ideation
Our priority is ensuring that registrants have access to advice and support, so that they can get the help they need and ensure they are able to continue to practise safely, without fear of the impact on their registration. To support this, we have produced online materials aimed at registrants and updated our guidance on health and character to include more illustrative case studies.
Reclassification of Gabapentin and Pregabalin
From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)